Cover Image
市場調查報告書

MRI系統:醫療設備的開發平台評估

Magnetic Resonance Imaging Systems - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 348493
出版日期 內容資訊 英文 320 Pages
訂單完成後即時交付
價格
Back to Top
MRI系統:醫療設備的開發平台評估 Magnetic Resonance Imaging Systems - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年09月01日 內容資訊: 英文 320 Pages
簡介

本報告提供MRI (磁振造影) 系統的開發中產品調查分析,以各開發階段比較分析為焦點,提供您包含正在開發開發中產品的主要企業,進行中的臨床試驗相關資訊等系統性資訊。

第1章 目錄

第2章 簡介

  • MRI系統概要

第3章 開發中的產品

  • MRI系統 - 開發中產品:各開發階段
  • MRI系統 - 開發中產品:各市場區隔
  • MRI系統 - 開發中產品:各地區
  • MRI系統 - 開發中產品:法規別
  • MRI系統 - 開發中產品:核准預定日別
  • MRI系統 - 進行中的臨床試驗

第4章 MRI系統 - 正在開發的開發中產品:各企業

  • MRI系統企業 - 開發中產品:各開發階段
  • MRI系統 - 開發中產品:各開發階段

第5章 MRI系統企業與產品概要

  • Advanced MRI Technologies
  • BioMers Products, LLC
  • C4 Imaging, LLC
  • Clear Cut Medical Ltd.
  • GE Healthcare
  • Harvard University
  • Hyper Tech Research, Inc.
  • KinetiCor Inc
  • Koninklijke Philips N.V.
  • Leiden University Medical Center
  • Marvel Medtech, LLC
  • Max-Delbruck-Centrum fur Molekulare Medizin (MDC)
  • MRI Robotics LLC
  • Neurospin
  • Philips Healthcare
  • Prism Clinical Imaging, Inc.
  • Siemens Healthcare
  • The University of Queensland
  • Time Medical, Inc.
  • Tornado Spectral Systems
  • University of California, San Diego
  • University of Colorado
  • University of Louisville
  • University of Minnesota
  • University of Nottingham
  • University of Texas Southwestern Medical Center at Dallas
  • VisionQuest Biomedical, LLC
  • Yeda Research and Development Company Ltd.

第6章 MRI系統 - 最近的趨勢

第7章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0420EPD

GlobalData's Medical Devices sector report, "Magnetic Resonance Imaging Systems - Medical Devices Pipeline Assessment, 2017" provides an overview of Magnetic Resonance Imaging Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Magnetic Resonance Imaging Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Magnetic Resonance Imaging Systems under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Magnetic Resonance Imaging Systems and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Magnetic Resonance Imaging Systems under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 9
  • 1.2 List of Figures 14

2 Introduction 15

  • 2.1 Magnetic Resonance Imaging Systems Overview 15

3 Products under Development 16

  • 3.1 Magnetic Resonance Imaging Systems - Pipeline Products by Stage of Development 16
  • 3.2 Magnetic Resonance Imaging Systems - Pipeline Products by Segment 17
  • 3.3 Magnetic Resonance Imaging Systems - Pipeline Products by Territory 18
  • 3.4 Magnetic Resonance Imaging Systems - Pipeline Products by Regulatory Path 19
  • 3.5 Magnetic Resonance Imaging Systems - Pipeline Products by Estimated Approval Date 20
  • 3.6 Magnetic Resonance Imaging Systems - Ongoing Clinical Trials 21

4 Magnetic Resonance Imaging Systems - Pipeline Products under Development by Companies 22

  • 4.1 Magnetic Resonance Imaging Systems Companies - Pipeline Products by Stage of Development 22
  • 4.2 Magnetic Resonance Imaging Systems - Pipeline Products by Stage of Development 25

5 Magnetic Resonance Imaging Systems Companies and Product Overview 28

  • 5.1 Advanced MRI Technologies Company Overview 28
  • 5.2 ALA Scientific Instruments Inc Company Overview 30
  • 5.3 Aspect Imaging Inc Company Overview 31
  • 5.4 Boston Children's Hospital Company Overview 32
  • 5.5 Brigham and Women's Hospital Company Overview 33
  • 5.6 Butterfly Network, Inc. Company Overview 36
  • 5.7 C4 Imaging, LLC Company Overview 37
  • 5.8 Cincinnati Children's Hospital Medical Center Company Overview 38
  • 5.9 Clear Cut Medical Ltd. Company Overview 39
  • 5.10 Diagnosoft Inc. Company Overview 44
  • 5.11 Duke University Company Overview 45
  • 5.12 Elekta AB Company Overview 47
  • 5.13 GE Global Research Company Overview 51
  • 5.14 GE Healthcare LLC Company Overview 52
  • 5.15 Georgetown University Company Overview 58
  • 5.16 Harvard University Company Overview 59
  • 5.17 Hugo W. Moser Research Institute at Kennedy Krieger Inc Company Overview 60
  • 5.18 Hyper Tech Research, Inc. Company Overview 62
  • 5.19 Insert Inc Company Overview 63
  • 5.20 John Hopkins University Company Overview 64
  • 5.21 KinetiCor Inc Company Overview 66
  • 5.22 Koninklijke Philips N.V. Company Overview 67
  • 5.23 Leiden University Company Overview 70
  • 5.24 Leiden University Medical Center Company Overview 71
  • 5.25 Marvel Medtech LLC Company Overview 72
  • 5.26 Max-Delbruck-Centrum fur Molekulare Medizin (MDC) Company Overview 74
  • 5.27 Medical College of Wisconsin Company Overview 75
  • 5.28 Mitsubishi Electric Corporation Company Overview 77
  • 5.29 MRI Robotics LLC Company Overview 78
  • 5.30 Neurospin Company Overview 79
  • 5.31 New York University School of Medicine Company Overview 80
  • 5.32 Northwestern University Company Overview 82
  • 5.33 Oregon Health & Science University Company Overview 83
  • 5.34 Philips Healthcare Company Overview 84
  • 5.35 Picofemto LLC Company Overview 86
  • 5.36 Prism Clinical Imaging, Inc. Company Overview 87
  • 5.37 Resonance Health Ltd Company Overview 88
  • 5.38 Robin Medical, Inc. Company Overview 89
  • 5.39 Siemens Healthcare GmbH Company Overview 91
  • 5.40 Stanford University Company Overview 101
  • 5.41 Tel Aviv University Company Overview 104
  • 5.42 Time Medical, Inc. Company Overview 105
  • 5.43 Tornado Spectral Systems Company Overview 107
  • 5.44 Toshiba Medical Systems Corporation Company Overview 108
  • 5.45 University of California Davis Company Overview 110
  • 5.46 University of California Los Angeles Company Overview 111
  • 5.47 University of California San Diego Company Overview 113
  • 5.48 University of California San Francisco Company Overview 114
  • 5.49 University of Colorado Company Overview 115
  • 5.50 University of Illinois Company Overview 118
  • 5.51 University of Louisville Company Overview 119
  • 5.52 University of Michigan Company Overview 120
  • 5.53 University of Minnesota Company Overview 121
  • 5.54 University of Nottingham Company Overview 122
  • 5.55 University of Queensland Company Overview 123
  • 5.56 University of Saskatchewan Company Overview 124
  • 5.57 University of Strasbourg Company Overview 125
  • 5.58 University of Texas Southwestern Medical Center Company Overview 126
  • 5.59 University of Virginia Company Overview 127
  • 5.60 University of Washington Company Overview 128
  • 5.61 Vanderbilt University Company Overview 130
  • 5.62 VisionQuest Biomedical, LLC Company Overview 132
  • 5.63 Wake Forest Baptist Medical Center Company Overview 133
  • 5.64 Weinberg Medical Physics, LLC Company Overview 134
  • 5.65 Weizmann Institute of Science Company Overview 135
  • 5.66 Wright State University Company Overview 136

6 Magnetic Resonance Imaging Systems- Recent Developments 137

  • 6.1 Aug 17, 2017: National Institutes of Health: Multicolor MRIs could aid disease detection 137
  • 6.2 Aug 10, 2017: Capitol Health: Preliminary Results for Period 1 July 2016 to 30 June 2017 137
  • 6.3 Aug 10, 2017: Varian Announces New VP of Investor Relations 138
  • 6.4 Aug 08, 2017: iCAD Reports Second Quarter 2017 Financial Results and Announces $13 Million Credit Facility With Silicon Valley Bank 138
  • 6.5 Aug 07, 2017: ViewRay Reports Second Quarter 2017 Financial Results 140
  • 6.6 Aug 07, 2017: MRI Contrast Agents Accumulate in the Brain 141
  • 6.7 Aug 04, 2017: SIGNA Premier 510(k) Cleared by the US FDA 142
  • 6.8 Aug 03, 2017: Elekta MR-linac Consortium Brings Founding Members Together With Clinicians From Five New Centers to Highlight Progress 143
  • 6.9 Aug 03, 2017: Siemens extends appointment of CEO Joe Kaeser 144
  • 6.10 Aug 03, 2017: Siemens: Earnings Release Q3 FY 2017 144
  • 6.11 Aug 03, 2017: Bruker Reports Second Quarter 2017 Financial Results 146
  • 6.12 Aug 03, 2017: Alliance HealthCare Services Reports Results for the Second Quarter and Six Months Ended June 30, 2017 148
  • 6.13 Aug 02, 2017: Hologic Announces Financial Results for Third Quarter of Fiscal 2017 150
  • 6.14 Aug 01, 2017: MRI Interventions Reports 79% Revenue Increase and Record Treatments in Second Quarter 2017 151
  • 6.15 Jul 28, 2017: Elekta's MR-linac Featured in 21 Abstracts at 2017 AAPM Annual Meeting 154
  • 6.16 Jul 26, 2017: Varian Medical Systems Reports Third Quarter Fiscal Year 2017 Results Highlighting Growth in Backlog and Improvements in both Gross Margin and Working Capital 155
  • 6.17 Jul 25, 2017: Catherine Estrampes appointed President & CEO of GE Healthcare Europe 156
  • 6.18 Jul 24, 2017: Philips' Second Quarter Results 2017 157
  • 6.19 Jul 24, 2017: Concord Medical Announces Changes to the Board 159
  • 6.20 Jul 21, 2017: EMA's final opinion confirms restrictions on use of linear gadolinium agents in body scans 160
  • 6.21 Jul 20, 2017: FDA clears first neonatal magnetic resonance imaging device 161
  • 6.22 Jul 20, 2017: Chief Business Leader of Philips' Personal Health businesses Pieter Nota to leave company 162
  • 6.23 Jul 20, 2017: fMRI, EEG may Provide Early Detection of Consciousness in Patients with Severe Traumatic Brain Injury 163
  • 6.24 Jul 13, 2017: Installation of Elekta MR-linac initiated at Sunnybrook Health Sciences Centre 164
  • 6.25 Jul 13, 2017: Analogic Appoints New Chief Financial Officer 165
  • 6.26 Jul 11, 2017: MRI Interventions Announces Record Second Quarter ClearPoint System Procedures, And a 79% Year-Over-Year Revenue Increase 165
  • 6.27 Jul 11, 2017: Toshiba Medical and AHRA Open Applications for Tenth Annual Putting Patients First Program 166
  • 6.28 Jul 07, 2017: UMMS researcher, colleagues develop tumor-targeting MRI contrast based on human protein 167
  • 6.29 Jun 29, 2017: Concord Medical Announces Construction of Proton Treatment Building of Beijing Proton Medical Center 168
  • 6.30 Jun 29, 2017: Gang Han, colleagues develop tumor-targeting MRI contrast based on human protein 168
  • 6.31 Jun 28, 2017: One Call Expands Operations in Springfield 169
  • 6.32 Jun 27, 2017: Study Suggests Intracranial Pathology Not Necessary for Gadolinium Deposition in Brain Tissues 169
  • 6.33 Jun 26, 2017: New Study Describes Changes to Structural Brain Networks After Radiotherapy for Brain Tumors 170
  • 6.34 Jun 21, 2017: Toshiba Medical Introduces New MR for Quiet, Comfortable and Complete Exams 171
  • 6.35 Jun 21, 2017: VNS Therapy Receives FDA Approval for Expanded MRI Labeling 172
  • 6.36 Jun 20, 2017: EPIC Alliance Discusses MR Conditional Devices and Best Practices at Europace-Cardiostim 2017 172
  • 6.37 Jun 15, 2017: FDA Clears MAGNETOM Vida 3T MRI System From Siemens Healthineers 173
  • 6.38 Jun 14, 2017: Artificial Intelligence Solution for the Substantial Iron Overload Market in Emerging Growth Markets 174
  • 6.39 Jun 13, 2017: BIOTRONIK Receives CE Mark for 3 Tesla Full-Body MRIs with Newest Pacemakers 175
  • 6.40 Jun 12, 2017: Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery 176
  • 6.41 Jun 09, 2017: CRL Launches New Tool For Breast Cancer Detection 177
  • 6.42 Jun 06, 2017: Analogic Announces Results for the Third Quarter Ended April 30, 2017 and Declares Quarterly Cash Dividend 177
  • 6.43 Jun 06, 2017: First-time exhibitors debut at Medtec China, Siemens PLM and FDA support onsite conference 179
  • 6.44 May 24, 2017: T2 Biosystems Announces Presentations at ASM Microbe 2017 Conference 180
  • 6.45 May 23, 2017: REPROCELL and Fox Chase Cancer Center Partner to Open Multi-Site Biosample Repository in India 181
  • 6.46 May 23, 2017: Brainlab Chief Financial Officer Joseph Doyle to Retire 181
  • 6.47 May 17, 2017: MR Solutions brings preclinical MRI to World Preclinical Congress in Boston 182
  • 6.48 May 17, 2017: Early MRI May Lower Costs for Prostate Cancer Treatment 183
  • 6.49 May 16, 2017: Charles J. Dockendorff Elected to Hologic Board of Directors 184
  • 6.50 May 15, 2017: Steinberg Diagnostic Medical Imaging Installs First Toshiba Medical Vantage Galan 3T 184
  • 6.51 May 15, 2017: ViewRay Reports First Quarter 2017 Financial Results 185
  • 6.52 May 11, 2017: Healthcare Veteran John Fletcher Joins MRI Interventions' Board of Directors 186
  • 6.53 May 10, 2017: Hologic Announces Financial Results for Second Quarter of Fiscal 2017 186
  • 6.54 May 10, 2017: Siemens Healthineers/Imricor Strategic Relationship Aims to Improve Procedures with MRI Scans of the Heart 188
  • 6.55 May 10, 2017: FONAR Announces Fiscal 2017 3rd Quarter and Nine Months Financial Results 188
  • 6.56 May 09, 2017: Alliance Healthcare Services Reports Results for the First Quarter Ended March 31, 2017 190
  • 6.57 May 04, 2017: Siemens: Earnings Release and Financial Results Q2 FY 2017: Another strong quarter - profitable growth continuing 192
  • 6.58 May 03, 2017: Bruker Reports First Quarter 2017 Financial Results 194
  • 6.59 May 02, 2017: iCAD Reports First-quarter 2017 Financial Results 194
  • 6.60 May 02, 2017: Brainlab Names New Member of Executive Board 196
  • 6.61 Apr 27, 2017: Toshiba Medical's Next-Generation MRI System Installed in Science + Technology Park at Johns Hopkins 196
  • 6.62 Apr 27, 2017: Varian Spotlights World-Leading Systems for Advanced Radiotherapy, Radiosurgery, Brachytherapy and Proton Therapy at ESTRO 36 197
  • 6.63 Apr 27, 2017: MRI Interventions Announces 2017 First Quarter Results 197
  • 6.64 Apr 27, 2017: ContextVision presents Q1 report 199
  • 6.65 Apr 26, 2017: Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2017 200
  • 6.66 Apr 24, 2017: Philips' First Quarter Results 2017 201
  • 6.67 Apr 21, 2017: Esaote showcases Dedicated MRI system at American Alliance of Orthopedic Executives 203
  • 6.68 Apr 21, 2017: Esaote announces new State of the Art - Manufacturing facility in Genoa 204
  • 6.69 Apr 20, 2017: Applications Open for ASRT Foundation and Toshiba Medical Safety FiRsT Grant Program 204
  • 6.70 Apr 18, 2017: New Evidence Demonstrates that FerriScan Results Are Not Impacted by Fatty Liver 205
  • 6.71 Apr 17, 2017: Toshiba Medical Names Dan Skyba Director of Ultrasound Business Unit 205
  • 6.72 Apr 10, 2017: Deep learning research consortium receives government grant 206
  • 6.73 Apr 06, 2017: MRI Interventions Announces Record Quarterly Revenue, Record ClearPoint System Procedures in 2017 First Quarter 206
  • 6.74 Apr 05, 2017: Varian Medical Systems Names New CFO 207
  • 6.75 Apr 04, 2017: Varian Medical Systems Establishes Direct Operation in South Africa 207
  • 6.76 Apr 03, 2017: Toshiba Medical introduces the new Vantage Titan 1.5T MRI System Zen Edition 207
  • 6.77 Apr 03, 2017: Toshiba Medical introduces the new Vantage Elan 1.5T MRI System Zen Edition 208
  • 6.78 Apr 03, 2017: Varian Medical Systems and Elekta Settle Patent Litigation 209
  • 6.79 Apr 03, 2017: Supervisory Board of Siemens Healthineers ensures management continuity 209
  • 6.80 Mar 30, 2017: Brainlab Displays Digital Integration in the Operating Room at Association of Perioperative Registered Nurses Global Surgical Conference & Expo 209
  • 6.81 Mar 27, 2017: Orthopedic Practice Improves Competitive Advantage with New Toshiba Medical MR System 210
  • 6.82 Mar 20, 2017: Philips reclassified to STOXX Europe 600 Health Care sector index 211
  • 6.83 Mar 17, 2017: Eva Schulz-Kamm appointed global head of Government Affairs at Siemens 211
  • 6.84 Mar 17, 2017: Philips appoints Henk de Jong as Chief of International Markets 211
  • 6.85 Mar 16, 2017: ViewRay Reports Fourth Quarter and Full Year 2016 Financial Results 212
  • 6.86 Mar 14, 2017: Radiology Oncology Systems is the new distributor for ScandiDos products in the Caribbean 213
  • 6.87 Mar 13, 2017: MRI scans can help spot HIV in the brain 213
  • 6.88 Mar 13, 2017: MRI-guided high-intensity focused ultrasound therapy for uterine fibroids has potential 214
  • 6.89 Mar 10, 2017: IMRIS, Deerfield Imaging appoints Robert C. Korn as Senior Vice President - Global Sales and Marketing 215
  • 6.90 Mar 09, 2017: Alliance HealthCare Services Reports Fourth Quarter & Full Year 2016 Results 216
  • 6.91 Mar 08, 2017: Toshiba Medical's Newest MRI System Tapped for UCI Brain Trauma Research 218
  • 6.92 Mar 08, 2017: iCAD Reports Fourth Quarter and Full Year 2016 Financial Results 218
  • 6.93 Mar 07, 2017: Philips leads the world in filing patents at the European Patent Office for second consecutive year 220
  • 6.94 Mar 06, 2017: Analogic Announces Results for the Second Quarter ended January 31, 2017 and Declares Quarterly Cash Dividend 221
  • 6.95 Mar 01, 2017: Philips introduces advanced radiology solutions at 2017 European Congress of Radiology to address evolving healthcare demands and support the changing role of the radiologist 223
  • 6.96 Mar 01, 2017: Jose Baselga and Jean-Luc Butel Appointed to Board of Directors of Varian Medical Systems 225
  • 6.97 Mar 01, 2017: Hologic to Showcase Groundbreaking Breast Cancer Screening and Interventional Solutions at European Congress of Radiology 2017 225
  • 6.98 Feb 28, 2017: Siemens Healthineers paves the way for precision medicine with BioMatrix technology and Magnetom Vida MRI scanner 226
  • 6.99 Feb 28, 2017: MRI Interventions Announces 2016 Fourth Quarter and Full Year Results 229
  • 6.100 Feb 24, 2017: Bupa Chile and Siemens Healthineers sign alliance to bring latest medical technology and services to Chile 232
  • 6.101 Feb 23, 2017: ContextVision presents Q4 and full year 2016 report 232
  • 6.102 Feb 22, 2017: TSRI Researchers Find Standard Pacemakers and Defibrillators Safe for MRI Using a New Protocol 233
  • 6.103 Feb 21, 2017: Philips increases Green Revenues to EUR 10.2 billion, 58% of HealthTech revenues in 2016 235
  • 6.104 Feb 21, 2017: FDA Clears Compressed Sensing MRI Acceleration Technology From Siemens Healthineers 235
  • 6.105 Feb 15, 2017: Researchers use MRIs to predict which high-risk babies will develop autism as toddlers 236
  • 6.106 Feb 14, 2017: Philips announces changes to its Executive Committee 237
  • 6.107 Feb 14, 2017: Massachusetts Institute of Technology: A new contrast agent for MRI 238
  • 6.108 Feb 13, 2017: FDA Clears Cost-efficient MAGNETOM Sempra MRI System From Siemens Healthineers 240
  • 6.109 Feb 13, 2017: Bruker Reports Fourth Quarter and Fiscal Year 2016 Financial Results 241
  • 6.110 Feb 13, 2017: Alliance Cancer Centers In Greenville And Clarksdale Add Radiation Oncologist, Gregg Alan Dickerson, M.d., Facr, Facro, To Staff 242
  • 6.111 Feb 13, 2017: Asteral Select delivers UK-first for UHL's Imaging Department 243
  • 6.112 Feb 09, 2017: FONAR Announces Fiscal 2017 2nd Quarter and Six Months Financial Results 244
  • 6.113 Feb 08, 2017: Siemens India announces Q1 FY 2017 results 246
  • 6.114 Feb 01, 2017: Jim Hagemann Snabe proposed as new Chairman of Siemens' Supervisory Board 246
  • 6.115 Feb 01, 2017: Hologic Announces Financial Results for First Quarter of Fiscal 2017 246
  • 6.116 Jan 31, 2017: Siemens: First Quarter Results FY 2017 248
  • 6.117 Jan 30, 2017: Study Published in the American Journal of Clinical Pathology Highlights Rapid Detection of Platelet Function Using T2MR Technology 248
  • 6.118 Jan 30, 2017: Varian Announces Successful Separation of Imaging Components Business 249
  • 6.119 Jan 25, 2017: Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2017 250
  • 6.120 Jan 24, 2017: Philips' Fourth Quarter and Annual Results 2016 251
  • 6.121 Jan 24, 2017: MRI Interventions Announces Year-End Update, Including 2016 Fourth Quarter and Full Year Revenues 254
  • 6.122 Jan 19, 2017: Philips appoints Roy Smythe as Chief Medical Officer for Health Informatics 255
  • 6.123 Jan 11, 2017: One Call Earns HITRUST Common Security Framework Certification 255
  • 6.124 Jan 04, 2017: Hologic Appoints President of EMEA and Canada, Completing International Leadership Team 256

7 Appendix 316

  • 7.1 Methodology 316
  • 7.2 About GlobalData 319
  • 7.3 Contact Us 319
  • 7.4 Disclaimer 319

List of Tables

1.1 List of Tables

  • Table 1: Magnetic Resonance Imaging Systems - Pipeline Products by Stage of Development 17
  • Table 2: Magnetic Resonance Imaging Systems - Pipeline Products by Segment 18
  • Table 3: Magnetic Resonance Imaging Systems - Pipeline Products by Territory 19
  • Table 4: Magnetic Resonance Imaging Systems - Pipeline Products by Regulatory Path 20
  • Table 5: Magnetic Resonance Imaging Systems - Pipeline Products by Estimated Approval Date 21
  • Table 6: Magnetic Resonance Imaging Systems - Ongoing Clinical Trials 22
  • Table 7: Magnetic Resonance Imaging Systems Companies - Pipeline Products by Stage of Development 23
  • Table 8: Magnetic Resonance Imaging Systems - Pipeline Products by Stage of Development 26
  • Table 9: Advanced MRI Technologies Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 10: MRI Cerebral Perfusion Imaging Tool - Product Status 29
  • Table 11: MRI Cerebral Perfusion Imaging Tool - Product Description 29
  • Table 12: Multiplexed EPI Imaging Sequence - Product Status 30
  • Table 13: Multiplexed EPI Imaging Sequence - Product Description 30
  • Table 14: ALA Scientific Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 15: fMRI Device - Brain Injury - Product Status 31
  • Table 16: fMRI Device - Brain Injury - Product Description 31
  • Table 17: Aspect Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 18: Stroke-dedicated MRI System - Product Status 32
  • Table 19: Stroke-dedicated MRI System - Product Description 32
  • Table 20: Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 21: Fetal Neuroimaging - Product Status 33
  • Table 22: Fetal Neuroimaging - Product Description 33
  • Table 23: Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 24: Diffusion Magnetic Resonance Imaging Tool - Chronic Traumatic Encephalopathy - Product Status 34
  • Table 25: Diffusion Magnetic Resonance Imaging Tool - Chronic Traumatic Encephalopathy - Product Description 34
  • Table 26: Magnetic Resonance Elastography - Product Status 35
  • Table 27: Magnetic Resonance Elastography - Product Description 35
  • Table 28: MRI - Head And Knee Imaging - Product Status 35
  • Table 29: MRI - Head And Knee Imaging - Product Description 36
  • Table 30: Butterfly Network, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 31: Handheld Ultrasound Device - Product Status 37
  • Table 32: Handheld Ultrasound Device - Product Description 37
  • Table 33: C4 Imaging, LLC Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 34: Sirius MRI Marker - Multi-Modality Imaging - Product Status 38
  • Table 35: Sirius MRI Marker - Multi-Modality Imaging - Product Description 38
  • Table 36: Cincinnati Children's Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 37: Pediatric Cardiovascular MRI - Product Status 39
  • Table 38: Pediatric Cardiovascular MRI - Product Description 39
  • Table 39: Clear Cut Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 40: ClearSight System - Breast Biopsy - Product Status 40
  • Table 41: ClearSight System - Breast Biopsy - Product Description 40
  • Table 42: ClearSight System - Colorectal Cancer - Product Status 41
  • Table 43: ClearSight System - Colorectal Cancer - Product Description 41
  • Table 44: ClearSight System - Lung Cancer - Product Status 41
  • Table 45: ClearSight System - Lung Cancer - Product Description 42
  • Table 46: ClearSight System - Prostate Cancer - Product Status 42
  • Table 47: ClearSight System - Prostate Cancer - Product Description 42
  • Table 48: ClearSight System - Skin Cancer - Product Status 43
  • Table 49: ClearSight System - Skin Cancer - Product Description 43
  • Table 50: ClearSight System - Thyroid Cancer - Product Status 43
  • Table 51: ClearSight System - Thyroid Cancer - Product Description 44
  • Table 52: Diagnosoft Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 53: Strain Encoding (SENC) Magnetic Resonance Imaging System - Product Status 45
  • Table 54: Strain Encoding (SENC) Magnetic Resonance Imaging System - Product Description 45
  • Table 55: Duke University Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 56: Neuro and Body MRI - Product Status 46
  • Table 57: Neuro and Body MRI - Product Description 46
  • Table 58: Next-Generation MRI Scanner - Product Status 47
  • Table 59: Next-Generation MRI Scanner - Product Description 47
  • Table 60: Elekta AB Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 61: MR-linac System - Product Status 48
  • Table 62: MR-linac System - Product Description 49
  • Table 63: Elekta AB - Ongoing Clinical Trials Overview 50
  • Table 64: MR-linac System - Magnetic Resonance Imaging (MRI) for the Delineation of Organs at Risk (OAR) and Target Volumes in Lung Cancer Patients 51
  • Table 65: MR-linac System - New Era in Cancer Treatment using Revolutionary Radiotherapy Machine 51
  • Table 66: GE Global Research Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 67: MRI Brain Scanner - Product Status 52
  • Table 68: MRI Brain Scanner - Product Description 52
  • Table 69: GE Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 70: 3.0 T Neonatal MRI scanner - Product Status 53
  • Table 71: 3.0 T Neonatal MRI scanner - Product Description 53
  • Table 72: Signa Creator - Product Status 54
  • Table 73: Signa Creator - Product Description 54
  • Table 74: Signa Explorer - Product Status 54
  • Table 75: Signa Explorer - Product Description 55
  • Table 76: SIGNA Pioneer - Product Status 55
  • Table 77: SIGNA Pioneer - Product Description 55
  • Table 78: Value MR - Product Status 56
  • Table 79: Value MR - Product Description 56
  • Table 80: GE Healthcare LLC - Ongoing Clinical Trials Overview 57
  • Table 81: 3.0 T Neonatal MRI scanner - Development of a MR Scanner Capable of Being Sited in a Neonatal Intensive Care Unit 58
  • Table 82: Georgetown University Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 83: Diagnostic Tool - Alzheimer's Disease - Product Status 59
  • Table 84: Diagnostic Tool - Alzheimer's Disease - Product Description 59
  • Table 85: Harvard University Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 86: Delta Relaxation Enhanced Magnetic Resonance - Product Status 60
  • Table 87: Delta Relaxation Enhanced Magnetic Resonance - Product Description 60
  • Table 88: Hugo W. Moser Research Institute at Kennedy Krieger Inc Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 89: GlucoCEST - Product Status 61
  • Table 90: GlucoCEST - Product Description 61
  • Table 91: MR Imaging - Neurological Diseases - Product Status 62
  • Table 92: MR Imaging - Neurological Diseases - Product Description 62
  • Table 93: Hyper Tech Research, Inc. Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 94: Magnesium Diboride (MgB2) Magnetic Resonance Imaging (MRI) System - Product Status 63
  • Table 95: Magnesium Diboride (MgB2) Magnetic Resonance Imaging (MRI) System - Product Description 63
  • Table 96: Insert Inc Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 97: inseRT MRI system - Product Status 64
  • Table 98: inseRT MRI system - Product Description 64
  • Table 99: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 100: Intravascular Magnetic Resonance Imaging - Product Status 65
  • Table 101: Intravascular Magnetic Resonance Imaging - Product Description 65
  • Table 102: MRI-Based Cancer Detection Device - Product Status 66
  • Table 103: MRI-Based Cancer Detection Device - Product Description 66
  • Table 104: KinetiCor Inc Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 105: Prospective Motion Correction Device - Product Status 67
  • Table 106: Prospective Motion Correction Device - Product Description 67
  • Table 107: Koninklijke Philips N.V. Pipeline Products & Ongoing Clinical Trials Overview 68
  • Table 108: Ingenia 1.5T S - Product Status 68
  • Table 109: Ingenia 1.5T S - Product Description 68
  • Table 110: Koninklijke Philips N.V. - Ongoing Clinical Trials Overview 69
  • Table 111: Ingenia 1.5T S - A Feasibility Study of Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia in Human Subjects 70
  • Table 112: Leiden University Pipeline Products & Ongoing Clinical Trials Overview 71
  • Table 113: Plasma Antenna - Product Status 71
  • Table 114: Plasma Antenna - Product Description 71
  • Table 115: Leiden University Medical Center Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 116: Multi-Information MRI - Product Status 72
  • Table 117: Multi-Information MRI - Product Description 72
  • Table 118: Marvel Medtech LLC Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 119: Solada - 4D - Product Status 73
  • Table 120: Solada - 4D - Product Description 73
  • Table 121: Solada - AT - Product Status 74
  • Table 122: Solada - AT - Product Description 74
  • Table 123: Solada - R - Product Status 74
  • Table 124: Solada - R - Product Description 74
  • Table 125: Max-Delbruck-Centrum fur Molekulare Medizin (MDC) Pipeline Products & Ongoing Clinical Trials Overview 75
  • Table 126: Fast Spin Echo MRI System - Product Status 75
  • Table 127: Fast Spin Echo MRI System - Product Description 75
  • Table 128: Medical College of Wisconsin Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 129: MR based Electrical Impedance Tomography - Breast Cancer - Product Status 76
  • Table 130: MR based Electrical Impedance Tomography - Breast Cancer - Product Description 76
  • Table 131: Multi-parametric MR Imaging - Spinal Disc Degeneration - Product Status 77
  • Table 132: Multi-parametric MR Imaging - Spinal Disc Degeneration - Product Description 77
  • Table 133: Simultaneous Multislice Imaging - Product Status 77
  • Table 134: Simultaneous Multislice Imaging - Product Description 77
  • Table 135: Mitsubishi Electric Corporation Pipeline Products & Ongoing Clinical Trials Overview 78
  • Table 136: Full-size MRI Scanner - Product Status 78
  • Table 137: Full-size MRI Scanner - Product Description 78
  • Table 138: MRI Robotics LLC Pipeline Products & Ongoing Clinical Trials Overview 79
  • Table 139: MRI-Guided Breast Biopsy Device - Product Status 79
  • Table 140: MRI-Guided Breast Biopsy Device - Product Description 79
  • Table 141: Neurospin Pipeline Products & Ongoing Clinical Trials Overview 80
  • Table 142: 11.7T MRI System - Product Status 80
  • Table 143: 11.7T MRI System - Product Description 80
  • Table 144: New York University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 81
  • Table 145: Magnetic Resonance Imaging Reconstruction - Product Status 81
  • Table 146: Magnetic Resonance Imaging Reconstruction - Product Description 81
  • Table 147: Pediatric MR Imaging - Product Status 82
  • Table 148: Pediatric MR Imaging - Product Description 82
  • Table 149: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 83
  • Table 150: MRI-Based - Oxygen Extraction Fraction - Product Status 83
  • Table 151: MRI-Based - Oxygen Extraction Fraction - Product Description 83
  • Table 152: Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview 84
  • Table 153: Contrast-Enhanced Magnetic Resonance Imaging - Product Status 84
  • Table 154: Contrast-Enhanced Magnetic Resonance Imaging - Product Description 84
  • Table 155: Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 85
  • Table 156: Magnetic Particle Imaging Scanner - Product Status 85
  • Table 157: Magnetic Particle Imaging Scanner - Product Description 85
  • Table 158: Multiva 1.5T MRI System - Product Status 86
  • Table 159: Multiva 1.5T MRI System - Product Description 86
  • Table 160: Picofemto LLC Pipeline Products & Ongoing Clinical Trials Overview 87

List of Figures

1.2 List of Figures

  • Figure 1: Magnetic Resonance Imaging Systems - Pipeline Products by Stage of Development 17
  • Figure 2: Magnetic Resonance Imaging Systems - Pipeline Products by Segment 18
  • Figure 3: Magnetic Resonance Imaging Systems - Pipeline Products by Territory 19
  • Figure 4: Magnetic Resonance Imaging Systems - Pipeline Products by Regulatory Path 20
  • Figure 5: Magnetic Resonance Imaging Systems - Pipeline Products by Estimated Approval Date 21
  • Figure 6: Magnetic Resonance Imaging Systems - Ongoing Clinical Trials 22
Back to Top